These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 25454318

  • 1. Sensitive measures of executive dysfunction in non-demented Parkinson's disease.
    Bott NT, Johnson ET, Schuff N, Galifianakis N, Subas T, Pollock J, Pressman P, Kramer JH, Possin KL.
    Parkinsonism Relat Disord; 2014 Dec; 20(12):1430-3. PubMed ID: 25454318
    [Abstract] [Full Text] [Related]

  • 2. CERAD test performance and cognitive impairment in Parkinson's disease.
    Karrasch M, Laatu S, Martikainen K, Marttila R.
    Acta Neurol Scand; 2013 Dec; 128(6):409-13. PubMed ID: 23668316
    [Abstract] [Full Text] [Related]

  • 3. Behavioural assessment of dysexecutive syndrome in Parkinson's disease without dementia: a comparison with other clinical executive tasks.
    Perfetti B, Varanese S, Mercuri P, Mancino E, Saggino A, Onofrj M.
    Parkinsonism Relat Disord; 2010 Jan; 16(1):46-50. PubMed ID: 19665420
    [Abstract] [Full Text] [Related]

  • 4. Longitudinal assessment of the pattern of cognitive decline in non-demented patients with advanced Parkinson's disease.
    Gasca-Salas C, Estanga A, Clavero P, Aguilar-Palacio I, González-Redondo R, Obeso JA, Rodríguez-Oroz MC.
    J Parkinsons Dis; 2014 Jan; 4(4):677-86. PubMed ID: 25208730
    [Abstract] [Full Text] [Related]

  • 5. Sleep correlates of trait executive function and memory in Parkinson's disease.
    Scullin MK, Fairley JA, Trotti LM, Goldstein FC, Factor SA, Bliwise DL.
    J Parkinsons Dis; 2015 Jan; 5(1):49-54. PubMed ID: 25588355
    [Abstract] [Full Text] [Related]

  • 6. Characterizing mild cognitive impairment in Parkinson's disease.
    Dalrymple-Alford JC, Livingston L, MacAskill MR, Graham C, Melzer TR, Porter RJ, Watts R, Anderson TJ.
    Mov Disord; 2011 Mar; 26(4):629-36. PubMed ID: 21287603
    [Abstract] [Full Text] [Related]

  • 7. Verbal Fluency as a Rapid Screening Test for Cognitive Impairment in Early Parkinson's Disease.
    Torralva T, Laffaye T, Báez S, Gleichgerrcht E, Bruno D, Chade A, Ibañez A, Manes F, Gershanik O, Roca M.
    J Neuropsychiatry Clin Neurosci; 2015 Mar; 27(3):244-7. PubMed ID: 26067437
    [Abstract] [Full Text] [Related]

  • 8. Resting state functional connectivity is associated with cognitive dysfunction in non-demented people with Parkinson's disease.
    Disbrow EA, Carmichael O, He J, Lanni KE, Dressler EM, Zhang L, Malhado-Chang N, Sigvardt KA.
    J Parkinsons Dis; 2014 Mar; 4(3):453-65. PubMed ID: 24662193
    [Abstract] [Full Text] [Related]

  • 9. A holistic analysis of relationships between executive function and memory in Parkinson's disease.
    Alonso Recio L, Martín P, Carvajal F, Ruiz M, Serrano JM.
    J Clin Exp Neuropsychol; 2013 Mar; 35(2):147-59. PubMed ID: 23289666
    [Abstract] [Full Text] [Related]

  • 10. Parkinson's disease-cognitive rating scale: a new cognitive scale specific for Parkinson's disease.
    Pagonabarraga J, Kulisevsky J, Llebaria G, García-Sánchez C, Pascual-Sedano B, Gironell A.
    Mov Disord; 2008 May 15; 23(7):998-1005. PubMed ID: 18381647
    [Abstract] [Full Text] [Related]

  • 11. Theory of mind deficits in Parkinson's disease: a product of executive dysfunction?
    Eddy CM, Beck SR, Mitchell IJ, Praamstra P, Pall HS.
    Neuropsychology; 2013 Jan 15; 27(1):37-47. PubMed ID: 23356595
    [Abstract] [Full Text] [Related]

  • 12. Olfactory deficits and cognitive dysfunction in Parkinson's disease.
    Parrao T, Chana P, Venegas P, Behrens MI, Aylwin ML.
    Neurodegener Dis; 2012 Jan 15; 10(1-4):179-82. PubMed ID: 22343138
    [Abstract] [Full Text] [Related]

  • 13. Executive dysfunction in non-demented Parkinson's disease patients with hallucinations.
    Imamura K, Wada-Isoe K, Kitayama M, Nakashima K.
    Acta Neurol Scand; 2008 Apr 15; 117(4):255-9. PubMed ID: 17922890
    [Abstract] [Full Text] [Related]

  • 14. Visual dysfunction in Parkinson disease without dementia.
    Uc EY, Rizzo M, Anderson SW, Qian S, Rodnitzky RL, Dawson JD.
    Neurology; 2005 Dec 27; 65(12):1907-13. PubMed ID: 16282276
    [Abstract] [Full Text] [Related]

  • 15. Assessing cognitive impairment in Parkinson's disease: a comparison of two tower tasks.
    McKinlay A, Grace RC, Kaller CP, Dalrymple-Alford JC, Anderson TJ, Fink J, Roger D.
    Appl Neuropsychol; 2009 Jul 27; 16(3):177-85. PubMed ID: 20183170
    [Abstract] [Full Text] [Related]

  • 16. Salience and Default Mode Network Coupling Predicts Cognition in Aging and Parkinson's Disease.
    Putcha D, Ross RS, Cronin-Golomb A, Janes AC, Stern CE.
    J Int Neuropsychol Soc; 2016 Feb 27; 22(2):205-15. PubMed ID: 26888617
    [Abstract] [Full Text] [Related]

  • 17. Characteristics of executive function impairment in Parkinson's disease patients without dementia.
    McKinlay A, Grace RC, Dalrymple-Alford JC, Roger D.
    J Int Neuropsychol Soc; 2010 Mar 27; 16(2):268-77. PubMed ID: 20003582
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: a randomized, double-blind, placebo-controlled, multicenter study.
    Hanagasi HA, Gurvit H, Unsalan P, Horozoglu H, Tuncer N, Feyzioglu A, Gunal DI, Yener GG, Cakmur R, Sahin HA, Emre M.
    Mov Disord; 2011 Aug 15; 26(10):1851-8. PubMed ID: 21500280
    [Abstract] [Full Text] [Related]

  • 20. Heterogeneity of letter fluency impairment and executive dysfunction in Parkinson's disease.
    Pettit L, McCarthy M, Davenport R, Abrahams S.
    J Int Neuropsychol Soc; 2013 Oct 15; 19(9):986-94. PubMed ID: 23953916
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.